Evogene Ltd. (EVGN)
NASDAQ: EVGN · Real-Time Price · USD
1.100
-0.005 (-0.45%)
Jun 6, 2025, 4:00 PM - Market closed
Evogene Market Cap
Evogene has a market cap or net worth of $7.57 million as of June 6, 2025. Its market cap has decreased by -78.82% in one year.
Market Cap
7.57M
Enterprise Value
16.95M
1-Year Change
-78.82%
Ranking
Category
Stock Price
$1.10
Market Cap Chart
Since October 15, 2007, Evogene's market cap has decreased from $28.02M to $7.57M, a decrease of -72.97%. That is a compound annual growth rate of -7.14%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 691.15B |
| Johnson & Johnson | 373.01B |
| AbbVie | 335.32B |
| Novo Nordisk | 332.47B |
| UnitedHealth Group | 275.06B |
| Abbott Laboratories | 232.41B |
| Novartis AG | 231.17B |
| AstraZeneca | 226.14B |